Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combiflex Omega is a parenteral nutrition solution designed to supply water, electrolytes, amino acids, calories, essential fatty acids (including omega-3 and omega-6), and other nutrients to patients who require intravenous nutrition due to limitations or impossibility of oral or gastrointestinal intake. It contains a high content of fish oil for optimal anti-inflammatory and immune function with an ω-6:ω-3 ratio of 2.1:1. The formulation also includes glucose and fat calories in compliance with ESPEN guidelines, as well as zinc and tocopherol (vitamin E) to enhance immune system function and antioxidant capacity. It is indicated for patients needing nutritional support via the jugular vein[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Combiflex Omega.